Rare diseases
Investigational molecules
Locations
Back to Germany1 770 clinical trials in Berlin, Germany across 17 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Study on the Effects of Tigulixostat and Allopurinol in Patients with Gout and High Uric Acid Levels
GermanyStudy of Pembrolizumab and Axitinib Combination Versus Sunitinib for Patients with Advanced or Metastatic Kidney Cancer
GermanyStudy on the Effectiveness and Safety of JNJ-77242113 for Treating Moderate to Severe Plaque Psoriasis in Adults
GermanyStudy on SAR444656 for Adults with Moderate to Severe Atopic Dermatitis
GermanyStudy on Long-Term Safety and Efficacy of Amlitelimab for Patients with Moderate to Severe Atopic Dermatitis from Previous Trials
GermanyStudy on the Effectiveness of PURETHAL Mites for Adults with Moderate to Severe Allergic Rhinitis or Rhinoconjunctivitis Due to House Dust Mite Allergy
GermanyStudy on the Effects of VER-01, Ibuprofen, and Paracetamol for Patients with Chronic Non-Specific Low Back Pain
GermanyStudy on Insulin Glargine for Patients with Type 2 Diabetes: Comparing Decentralized, Hybrid, and Standard Clinical Trial Approaches
GermanyStudy on BI 685509 for Adults with Systemic Sclerosis to Assess Effects on Lung Function and Symptoms
GermanyStudy on the Long-Term Safety and Effectiveness of Minzasolmin and Iodine Ioflupane (123I) in Patients with Parkinson's Disease
GermanyStudy on the Effects of MORF-057 for Adults with Moderate to Severe Ulcerative Colitis
GermanyStudy on Izokibep for Improving Symptoms in Patients with Active Psoriatic Arthritis
GermanyThe busiest research cities in the country
What the registry says about research in the country
Advanced clinical trials focusing on various cancer treatments, including studies of metastatic prostate cancer, colorectal cancer, and innovative approaches for breast cancer treatment.
Novel combination therapies and targeted treatments are being evaluated to improve patient outcomes across multiple cancer types.
Comprehensive vaccine development programs targeting various viral infections, including studies on respiratory syncytial virus, cytomegalovirus, and herpes zoster.
These trials aim to enhance immune response and provide long-term protection against serious viral infections.
Innovative treatments for various chronic conditions, including autoimmune dementia, hypertriglyceridemia, and studies in transplant medicine.
Research focuses on developing targeted therapies and improving treatment outcomes for long-term conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
